Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
319.7 USD | +0.10% | +2.90% | +18.24% |
Apr. 22 | Mizuho Adjusts Price Target on HCA Healthcare to $370 From $345 | MT |
Apr. 22 | Ondine Biomedical celebrates use of Steriwave in Australian hospital | AN |
Evolution of the average Target Price on HCA Healthcare, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering HCA Healthcare, Inc.
Mizuho Securities | |
Truist Securities | |
Deutsche Bank Securities | |
Wells Fargo Securities | |
UBS | |
Raymond James | |
Oppenheimer | |
RBC Capital Markets | |
Bernstein | |
Goldman Sachs | |
Argus | |
JPMorgan Chase | |
Stephens Inc. | |
Baptista Research | |
Credit Suisse | |
Barclays | |
Jefferies & Co. | |
Citigroup | |
BofA Securities | |
TD Cowen | |
Loop Capital | |
Cantor Fitzgerald | |
Cowen | |
SVB Securities LLC | |
BMO Capital | |
SVB Leerink | |
Seaport Global Securities |
EPS Revisions
- Stock Market
- Equities
- HCA Stock
- Consensus HCA Healthcare, Inc.